$TNXP Cashflow Statement | Understand Stock

$TNXP

$5.39 +$0.09 (1.7%) Close

$TNXP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Common stock issued to acquire in-process research and development
Bad debt expense
Asset impairment charges
Stock-based compensation
Change in fair value of warrant liabilities
Offering costs allocated to warrant liabilities
Loss on extinguishment of debt
Loss on note
Inventory write-off
Amortization of debt discounts
Gain on sale of property and equipment
Issuance costs of derivative instrument

Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other
Accounts payable
Operating lease liabilities and ROU asset, net
Accrued expenses and other current liabilities
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of business
Disposal of property and equipment
Issuance of note
Proceeds from note
Purchase of property and equipment
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of warrants
Deferred payment related to purchase of business
Proceeds from ESPP
Proceeds, net of $6,659 expenses, from sale of convertible redeemable preferred stock
Repayments of term loan
Redemption of convertible preferred stock
Proceeds from debt financing
Proceeds, net of $8,750 and $7,238 expenses, from sale of common stock and warrants, respectively
Proceeds from allocated warrant liabilities
Repurchase of common stock, net of $30 expenses
Net cash provided by financing activities

Effect of currency rate change on cash
Net increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash beginning of the period
Cash, cash equivalents and restricted cash end of period
Supplemental disclosures of cash flow information:
Purchases of property and equipment included in accounts payable and accrued liabilities
Interest paid
Non cash investing and financing activity:
Purchases of property and equipment included in accounts payable and accrued liabilities
Net ATM proceeds received after year-end
Debt financing costs included in accrued liabilities and other current liabilities
Issuance costs included in accrued liabilities and other current liabilities
Preferred stock deemed dividend
Issuance costs from derivative instruments
New operating leases and lease amendments

Comments